American Journal of Chinese Medicine

The American Journal of Chinese Medicine is an international peer-reviewed journal published by World Scientific, founded in 1973 and devoted to traditional and indigenous medicine across cultures, with a 2025 Journal Impact Factor of 7.8《美国中医药杂志》由（World Scientific）出版，创刊于 1973 年，是经同行评审的国际期刊，致力于跨文化的传统医学与民族医学研究，2025 年影响因子为 7.8。

Scope

• Basic scientific and clinical research on indigenous medical techniques, therapeutic procedures and medicinal plants is central to the journal对本土医疗技术、治疗程序与药用植物的基础科学与临床研究是该刊的核心。
• Traditional medical theories and concepts are examined from historical, cultural and public health perspectives传统医学理论与概念从历史、文化与公共卫生视角受到考察。
• Acupuncture, moxibustion and other manual therapies are studied through controlled and mechanistic research针灸、艾灸与其他手法疗法通过对照研究与机制研究加以探讨。
• Ethnopharmacology, phytochemistry and the quality control of herbal medicines fall within its scope民族药理学、植物化学与草药质量控制属于其范围。
• Multidisciplinary work on medical practice and health care, including socioeconomic and policy analysis, is welcomed关于医疗实践与卫生保健的多学科研究，包括社会经济与政策分析，均受欢迎。
• Comparative studies of medicine in different cultures and their international policy implications are published该刊发表不同文化间医学的比较研究及其国际政策含义。
• Translations and critical editions of classical medical texts and modern ethnomedical publications are also considered古典医学文献的翻译与考订版本以及现代民族医学出版物也在考虑之列。

History

• The journal was founded in 1973 by Frederick F. Kao, who served as its first editor-in-chief until 1992该刊由（Frederick F. Kao）于 1973 年创办，他担任首任主编至 1992 年。
• World Scientific has published the journal since 1979, giving it a distribution base in Singapore and the wider Asia-Pacific region（World Scientific）自 1979 年起出版该刊，使其在新加坡及更广泛的亚太地区具备发行基础。
• John J. Kao edited the journal from 1993 to 2003, and Chun-Su Yuan has held the editorship since 2003（John J. Kao）于 1993 年至 2003 年任主编，（Chun-Su Yuan）自 2003 年起接任。
• It appears eight times a year and publishes original papers, reviews, editorials, policy statements, letters and book reviews该刊每年出版 8 期，刊登原创论文、综述、社论、政策声明、读者来信与书评。
• Its Journal Impact Factor rose from 4.667 in 2021 and 6.005 in 2022 to 5.5 in 2024 and 7.8 in 2025其影响因子由 2021 年的 4.667 与 2022 年的 6.005，变为 2024 年的 5.5 与 2025 年的 7.8。
• The journal is indexed in Science Citation Index Expanded, Index Medicus and Biological Abstracts该刊被（Science Citation Index Expanded）、（Index Medicus）与（Biological Abstracts）收录。

Editors

• The editor-in-chief is Chun-Su Yuan of the University of Chicago, who has led the journal since 2003现任主编为（University of Chicago）的（Chun-Su Yuan），自 2003 年起主持该刊。
• Frederick F. Kao, the founding editor, and John J. Kao shaped the journal's early editorial direction创始主编（Frederick F. Kao）与（John J. Kao）奠定了该刊早期的编辑方向。
• An international editorial board covers pharmacology, clinical trials, history of medicine and health policy国际编委会的覆盖范围包括药理学、临床试验、医学史与卫生政策。
• Authors must follow the Declaration of Helsinki and the Guiding Principles and Procedures of the Massachusetts General Hospital on Human Studies作者须遵循《赫尔辛基宣言》以及（Massachusetts General Hospital）关于人体研究的指导原则与程序。
• Research involving endangered species or inappropriate animal experimentation is not accepted涉及濒危物种或以不当方式使用动物实验的研究不予接受。
• Submissions are peer reviewed, and the journal publishes editorials and social policy statements alongside research articles投稿须经同行评审，该刊在研究论文之外亦刊发社论与社会政策声明。